| scholarly article | Q13442814 |
| P2093 | author name string | Michel Liuzzi | |
| Stephen W Mason | |||
| Paul Whitehead | |||
| Carol Lawetz | |||
| Erika Aberg | |||
| Rachel DeLong | |||
| P2860 | cites work | Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses | Q24797827 |
| Transcription of eukaryotic protein-coding genes | Q28138540 | ||
| Respiratory syncytial virus M2-1 protein requires phosphorylation for efficient function and binds viral RNA during infection | Q31030915 | ||
| Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus | Q33598973 | ||
| The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription | Q33782056 | ||
| Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription. | Q33815697 | ||
| Requirement of cysteines and length of the human respiratory syncytial virus M2-1 protein for protein function and virus viability | Q33849620 | ||
| Processive antitermination | Q33990979 | ||
| Mapping the transcription and replication promoters of respiratory syncytial virus | Q34331065 | ||
| Regulation of transcription elongation by phosphorylation | Q34816680 | ||
| RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA | Q35845933 | ||
| Effects of mutations in the gene-start and gene-end sequence motifs on transcription of monocistronic and dicistronic minigenomes of respiratory syncytial virus. | Q35870453 | ||
| Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene | Q37611890 | ||
| Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: significance for nucleocapsid assembly and formation of cytoplasmic inclusions | Q38362415 | ||
| Structural phosphoprotein M2-1 of the human respiratory syncytial virus is an RNA binding protein | Q39539425 | ||
| Diverse gene junctions of respiratory syncytial virus modulate the efficiency of transcription termination and respond differently to M2-mediated antitermination | Q39548629 | ||
| The Cys(3)-His(1) motif of the respiratory syncytial virus M2-1 protein is essential for protein function | Q39591633 | ||
| Casein kinase 2-mediated phosphorylation of respiratory syncytial virus phosphoprotein P is essential for the transcription elongation activity of the viral polymerase; phosphorylation by casein kinase 1 occurs mainly at Ser(215) and is without effe | Q39595915 | ||
| Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication. | Q39869698 | ||
| Synergistic effects of gene-end signal mutations and the M2-1 protein on transcription termination by respiratory syncytial virus | Q40774679 | ||
| Deletion and substitution analysis defines regions and residues within the phosphoprotein of bovine respiratory syncytial virus that affect transcription, RNA replication, and interaction with the nucleoprotein | Q40794840 | ||
| Transcriptional antitermination | Q40825617 | ||
| Regulated but not constitutive human respiratory syncytial virus (HRSV) P protein phosphorylation is essential for oligomerization | Q40900083 | ||
| Cytoplasmic inclusions of respiratory syncytial virus-infected cells: formation of inclusion bodies in transfected cells that coexpress the nucleoprotein, the phosphoprotein, and the 22K protein | Q41545377 | ||
| Mapping of monoclonal antibody epitopes of the human respiratory syncytial virus p protein | Q41546494 | ||
| Using protein affinity chromatography to probe structure of protein machines. | Q44405261 | ||
| Mapping the domains on the phosphoprotein of bovine respiratory syncytial virus required for N-P and P-L interactions using a minigenome system | Q44880193 | ||
| Domains of human respiratory syncytial virus P protein essential for homodimerization and for binding to N and NS1 protein | Q45741008 | ||
| Support plasmids and support proteins required for recovery of recombinant respiratory syncytial virus | Q45748721 | ||
| Characterization of the interaction of the human respiratory syncytial virus phosphoprotein and nucleocapsid protein using the two-hybrid system | Q45753973 | ||
| Kinetics of synthesis and phosphorylation of respiratory syncytial virus polypeptides | Q45832430 | ||
| Bacterial expression of human respiratory syncytial viral phosphoprotein P and identification of Ser237 as the site of phosphorylation by cellular casein kinase II | Q72843509 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | respiratory syncytial virus | Q1052913 |
| RSV phosphoprotein | Q115694242 | ||
| RSV matrix 2-1 protein | Q115694288 | ||
| P304 | page(s) | 10670-10676 | |
| P577 | publication date | 2003-10-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Interaction between human respiratory syncytial virus (RSV) M2-1 and P proteins is required for reconstitution of M2-1-dependent RSV minigenome activity | |
| P478 | volume | 77 |
| Q36208181 | A Druggable Pocket at the Nucleocapsid/Phosphoprotein Interaction Site of Human Respiratory Syncytial Virus |
| Q36845860 | Association of respiratory syncytial virus M protein with viral nucleocapsids is mediated by the M2-1 protein |
| Q45634300 | Biochemical characterization of the respiratory syncytial virus P-P and P-N protein complexes and localization of the P protein oligomerization domain |
| Q36171959 | Characterization of a viral phosphoprotein binding site on the surface of the respiratory syncytial nucleoprotein |
| Q64101963 | Contribution of Fcγ Receptor-Mediated Immunity to the Pathogenesis Caused by the Human Respiratory Syncytial Virus |
| Q92739915 | Cryo-EM structure of the respiratory syncytial virus RNA polymerase |
| Q27681365 | Crystal structure of the essential transcription antiterminator M2-1 protein of human respiratory syncytial virus and implications of its phosphorylation |
| Q40443431 | Determination of phosphorylated residues from human respiratory syncytial virus P protein that are dynamically dephosphorylated by cellular phosphatases: a possible role for serine 54. |
| Q40115600 | Dynamic Phosphorylation of VP30 Is Essential for Ebola Virus Life Cycle |
| Q40413349 | Evidence for an association between heat shock protein 70 and the respiratory syncytial virus polymerase complex within lipid-raft membranes during virus infection |
| Q40495747 | Evidence that the respiratory syncytial virus polymerase complex associates with lipid rafts in virus-infected cells: a proteomic analysis |
| Q40236638 | Fine modulation of the respiratory syncytial virus M2-1 protein quaternary structure by reversible zinc removal from its Cys(3)-His(1) motif |
| Q40721101 | Functional correlations of respiratory syncytial virus proteins to intrinsic disorder. |
| Q41701408 | Functional organization of cytoplasmic inclusion bodies in cells infected by respiratory syncytial virus |
| Q37599051 | Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure |
| Q116170837 | Helical ordering of envelope‐associated proteins and glycoproteins in respiratory syncytial virus |
| Q40590069 | Human Respiratory Syncytial Virus: Infection and Pathology. |
| Q90168333 | Identification of a human respiratory syncytial virus phosphoprotein domain required for virus-like-particle formation |
| Q34045568 | Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase |
| Q45354796 | Modular unfolding and dissociation of the human respiratory syncytial virus phosphoprotein p and its interaction with the m(2-1) antiterminator: a singular tetramer-tetramer interface arrangement |
| Q40403859 | New Insights into Structural Disorder in Human Respiratory Syncytial Virus Phosphoprotein and Implications for Binding of Protein Partners. |
| Q26737717 | New antiviral approaches for respiratory syncytial virus and other mononegaviruses: Inhibiting the RNA polymerase |
| Q52644426 | Nucleosides for the treatment of respiratory RNA virus infections. |
| Q39958858 | Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex: impact on viral transcription and replication |
| Q45392041 | Phosphorylation of human respiratory syncytial virus P protein at serine 54 regulates viral uncoating |
| Q45410222 | Phosphorylation of human respiratory syncytial virus P protein at threonine 108 controls its interaction with the M2-1 protein in the viral RNA polymerase complex |
| Q40948804 | Phosphorylation of the human respiratory syncytial virus P protein mediates M2-2 regulation of viral RNA synthesis, a process that involves two P proteins |
| Q37537503 | Polyadenylation-dependent screening assay for respiratory syncytial virus RNA transcriptase activity and identification of an inhibitor |
| Q37984106 | Protein-protein interactions in RSV assembly: potential targets for attenuating RSV strains. |
| Q41656620 | Quantitative investigation of the affinity of human respiratory syncytial virus phosphoprotein C-terminus binding to nucleocapsid protein |
| Q52371568 | RSV hijacks cellular protein phosphatase 1 to regulate M2-1 phosphorylation and viral transcription. |
| Q43807295 | Residues in human respiratory syncytial virus P protein that are essential for its activity on RNA viral synthesis. |
| Q112294993 | Respiratory syncytial virus M2-1 protein associates non-specifically with viral messenger RNA and with specific cellular messenger RNA transcripts |
| Q27680597 | Solution and Crystallographic Structures of the Central Region of the Phosphoprotein from Human Metapneumovirus |
| Q30580524 | Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex |
| Q40339018 | Structural analysis of the human respiratory syncytial virus phosphoprotein: characterization of an alpha-helical domain involved in oligomerization |
| Q44842648 | Structural dissection of human metapneumovirus phosphoprotein using small angle x-ray scattering |
| Q27679531 | Structure and Functional Analysis of the RNA- and Viral Phosphoprotein-Binding Domain of Respiratory Syncytial Virus M2-1 Protein |
| Q93177879 | Structure of the Respiratory Syncytial Virus Polymerase Complex |
| Q91167102 | Structure of the human metapneumovirus polymerase phosphoprotein complex |
| Q38798541 | Structure-guided design of small-molecule therapeutics against RSV disease |
| Q59137640 | The Structure of the Human Respiratory Syncytial Virus M2-1 Protein Bound to the Interaction Domain of the Phosphoprotein P Defines the Orientation of the Complex |
| Q45409156 | The nine C-terminal amino acids of the respiratory syncytial virus protein P are necessary and sufficient for binding to ribonucleoprotein complexes in which six ribonucleotides are contacted per N protein protomer |
| Q41361265 | The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner |
| Q45363775 | The respiratory syncytial virus transcription antiterminator M(2-1) is a highly stable, zinc binding tetramer with strong pH-dependent dissociation and a monomeric unfolding intermediate |
| Q36499709 | Unravelling the complexities of respiratory syncytial virus RNA synthesis. |
Search more.